GE Health asks EMA to reconsider proposal to stop sale of MRI drug

(Reuters) - General Electric Co's healthcare business said it had requested the European Medicines Agency to reconsider the recommendation made by its panel to suspend the marketing authorization of certain agents used in MRI scanning.